Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2023 Earnings Call Transcript May 4, 2023
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.4, expectations were $-1.76.
Operator: Thank you for standing by and welcome to the Alnylam Pharmaceuticals First Quarter 2023 Financial Results Conference Call. As a reminder today’s conference call is being recorded. I would now like to turn the conference over to the company. Please go ahead.
Christine Lindenboom: Good...
